The challenges of using oligonucleotides for therapeutic applications in oncology is an interesting subject. We spoke with Charles Sinclair, Senior Principal Scientist, Bristol-Myers Squibb to find more. This episode is also a fantastic insight for you to hear what the future holds for oligonucleotides.
Presented by Louise Laurent, Professor, Department of OB/GYN and Reproductive Sciences | Gene Yeo, COVID-19 individual testing workflow, Professor, Department of Cellular and Molecular Medicine | Rob Knight, COVID-19 wastewater testing program, Professor, Department of Paediatrics | Peter DeHoff, Mosquito automation and miniaturization, Project Scientist, Department of OB/GYN& Reproductive Sciences
Presented by Vladimir Benes, Head of Genomics Core Facility, EMBL | Gahee Park, CRUK Early Detection Programme, Department of Oncology, University of Cambridge | Chaithanya Ponnaluri, New England Biolabs
Presented by Christina Curtis, PhD, Associate Professor, Medicine - Oncology - Stanford University | Ioannis Vlachos , PhD, Assistant Professor of Pathology, Beth Israel Deaconess Medical Center | Arutha Kulasinghe, PhD, NHMRC Research Fellow, Queensland University of Technology | Patrick Danaher, PhD, Principle Statistician Nanostring
Presented by Dr Guillaume Pavlovic, Head of Unit - Genetic Engineering & Model Validation Department, PHENOMIN - ICS - IGBMC
October 29, 2020
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.